Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 6, 2012

View Archived Issues

Novel antithrombotic agents presented by Bristol-Myers Squibb

New tamsulosin prodrugs prepared by Synthon

Affectis Pharmaceuticals presents novel P2X7 receptor antagonists

Novel monoclonal antibodies patented by IRM and Novartis

Mepolizumab reduces exacerbation rates in asthma patients

Third patient successfully treated with Pluristem's PLX cells

Phase I/II ublituximab trial begins in B-cell non-Hodgkin's lymphoma

Researchers at Zyngenia disclose novel fusion proteins

Light study of Contrave experiences accelerated enrollment

Oncothyreon expands phase II trial of PX-866

Novel S1P4 receptor antagonists synthesized by Biogen Idec

ImmunoCellular Therapeutics completes enrollment in ICT-107 trial

BT-2111 shows promise in animal models of breast cancer

Adynxx's AYX-1 set to move to phase II

Targacept to develop TC-5214 in overactive bladder

Phase II results demonstrate efficacy of QMF-149 in patients with persistent asthma

ALV-003 receives FDA fast track designation for celiac disease

New lysophospholipid S1P1 receptor agonists presented at ACS meeting

Rienso receives Swiss marketing authorization

NPS Pharmaceuticals updates plans for Natpara BLA

Baxter begins phase I monoclonal antibody trial in patients with solid tumors

Acadia Pharmaceuticals completes enrollment in phase III pimavanserin trial

Study evaluates dose-response of umeclidinium in COPD

Meda to buy Jazz Pharmaceuticals' women's health business

FDA extends PDUFA date for Ravicti NDA

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...